PHOENIX, Aug. 6, 2020 /PRNewswire/ -- SenesTech, Inc.
(NASDAQ: SNES), a developer of proprietary technologies for
managing animal pest populations through fertility control, will
report financial results for its second quarter 2020, ended
June 30, 2020, after the market close
on Wednesday, August 12, 2020. The
Company has scheduled a conference call that same day, Wednesday, August 12, 2020, at 5:00 pm ET, to review the results.
Second Quarter 2020 Conference Call Details
Date and Time: Wednesday, August
12, 2020 at 5:00 pm ET
Call-in Information: Interested parties can access the
conference call by dialing (844) 308-3351 or (412) 317-5407.
Live Webcast Information: Interested parties can access
the conference call via a live Internet webcast, which is available
in the Investor Relations section of the Company's website at
http://senestech.investorroom.com/.
Replay: A teleconference replay of the call will be
available for three days at (877) 344-7529 or (412) 317-0088,
confirmation #10147160. A webcast replay will be available in the
Investor Relations section of the Company's website at
http://senestech.investorroom.com/ for 90 days.
About SenesTech
SenesTech is changing the model for pest management by targeting
one of the root causes of the problem: reproduction.
ContraPest® is an innovative technology with an approach that
targets the reproductive capabilities of both sexes in rat
populations, inducing egg loss in female rats and impairing sperm
development in males. Using a proprietary bait delivery method,
ContraPest® is dispensed in a highly palatable liquid formulation
that promotes sustained consumption by rat communities. ContraPest®
is designed, formulated and dispensed to be low hazard for handlers
and non-target species such as wildlife, livestock and pets, where
the active ingredients break down rapidly.
We believe ContraPest® will establish a new paradigm in rodent
control, resulting in a decreased reliance on lethal options. For
more information visit the SenesTech website at
www.senestech.com.
Safe Harbor Statement
The foregoing
paragraphs contain forward-looking statements that involve
estimates, assumptions, risks and uncertainties. Any statements
about our expectations, beliefs, plans, objectives, assumptions or
future events or performance are not historical facts and may be
forward-looking. "Forward-looking statements" may be preceded by
words such as "may," "future," "plan" or "planned," "will,"
"should," "expected," "anticipates," "continue," "eventually,"
"believes," or "projected." Forward-looking statements include
statements concerning the potential impact and effects of the
COVID-19 pandemic on the Company's business, results of operations
and financial performance; any measures the Company has and may
take in response to COVID-19 and any expectations the Company may
have with respect thereto; the Company's strategy and target
marketing and markets; continuing the Company's vision; expected
benefits of the Company's initiatives and continuation of those
initiatives; deployment of the Company's product; the continuation
or expansion of the use of ContraPest; demand for ContraPest; the
Company's expectation regarding costs, expenses and cash and
continuing its cost improvement plan; future financial results; and
the Company's execution of its strategic business plan.
CONTACT:
Investor: Robert Blum, Lytham
Partners, LLC, 602-889-9700, senestech@lythampartners.com
Company: Tom Chesterman, Chief
Financial Officer, SenesTech, Inc., 928-779-4143
View original content to download
multimedia:http://www.prnewswire.com/news-releases/senestech-to-report-second-quarter-2020-financial-results-on-wednesday-august-12-2020-301107245.html
SOURCE SenesTech, Inc.